It remains unclear if Trpc6 mutations require an as yet unidentified environmental or genetic hit to induce glomerular disease in mice, or if mice are intrinsically not suitable to model TRPC6-mediated human FSGS. The gene discussed is TRPC6; the disease is focal segmental glomerulosclerosis.